3 búsqueda de la palabra clave 'Quality of life'

End-of-life transfusions in patients with an oncological diagnosis / Juan Felipe Vargas Silva    

Público ISBD Título : End-of-life transfusions in patients with an oncological diagnosis Otros títulos : Transfusiones al final de la vida en pacientes con diagnóstico oncológico Tipo de documento : documento electrónico Autores : Juan Felipe Vargas Silva, Fecha de publicación : 2021 Títulos uniformes : Revista de la Sociedad Española del Dolor Idioma : Inglés (eng) Palabras clave : Blood transfusion  hospice care  quality of life  cancer  pain Resumen : Introduction: Cancer patients in terminal stages present symptoms related to anemia, other cytopenias, and coagulopathies that deteriorate the quality of life. These symptoms can be multicausal and do not improve in most cases. Objective: Describe the use of blood transfusions in the six months before death as an alternative palliative treatment in patients with an oncological diagnosis in the city of Medellin during the period 2013-2018. Methods: Retrospective cohort, in patients with a cancer diagnosis who received transfusions in the last six months of life, a non-probabilistic sampling of consecutive cases was executed. The analysis was carried out in SPSS, estimating absolute and relative frequencies and median with interquartile ranges. Results: Out of 3,254 medical records of cancer pa­tients, 151 were included. The time to oncological diagnosis had a median of 2 years (IQR 1 and 3). The symptoms observed in patients before and after the first transfusion were pain, present in 32.1 % (46) and 16.9 % (25) respectively, besides drowsiness was distinguished in 25 % (36) before transfusion and 14.3 % (21) after. Finally, the clinical outcomes before and after the last transfusion prior to death, were a decrease in pain, asthenia/adynamia, drowsiness, among others. Conclusions: The findings of this research allow us to appreciate the current panorama in the institutions in which palliative care medical services are being provided and consider when to offer the blood products to a patient at the end of life as a therapeutic measure in the context of a human being cared by physicians. Mención de responsabilidad : AP Brome Uribe, LM Martínez Sánchez, L Herrera-Almanza, M Fonseca-Guzmán, C Durango-Sánchez, V Vasquez-Estrada, L Duque-Echeverri, A Morales-Montoya, ME Saavedra-Valencia, JF Vargas-Silva, SM Molina-Giraldo DOI (Digital Object Identifier) : 10.20986/resed.2022.3956/2021 Derechos de uso : CC BY-NC-ND En línea : https://www.resed.es/transfusiones-al-final-de-la-vida-en-pacientes-con-diagnost [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5991 End-of-life transfusions in patients with an oncological diagnosis = Transfusiones al final de la vida en pacientes con diagnóstico oncológico [documento electrónico] / Juan Felipe Vargas Silva,  . - 2021. Obra : Revista de la Sociedad Española del Dolor Idioma : Inglés (eng) Palabras clave : Blood transfusion  hospice care  quality of life  cancer  pain Resumen : Introduction: Cancer patients in terminal stages present symptoms related to anemia, other cytopenias, and coagulopathies that deteriorate the quality of life. These symptoms can be multicausal and do not improve in most cases. Objective: Describe the use of blood transfusions in the six months before death as an alternative palliative treatment in patients with an oncological diagnosis in the city of Medellin during the period 2013-2018. Methods: Retrospective cohort, in patients with a cancer diagnosis who received transfusions in the last six months of life, a non-probabilistic sampling of consecutive cases was executed. The analysis was carried out in SPSS, estimating absolute and relative frequencies and median with interquartile ranges. Results: Out of 3,254 medical records of cancer pa­tients, 151 were included. The time to oncological diagnosis had a median of 2 years (IQR 1 and 3). The symptoms observed in patients before and after the first transfusion were pain, present in 32.1 % (46) and 16.9 % (25) respectively, besides drowsiness was distinguished in 25 % (36) before transfusion and 14.3 % (21) after. Finally, the clinical outcomes before and after the last transfusion prior to death, were a decrease in pain, asthenia/adynamia, drowsiness, among others. Conclusions: The findings of this research allow us to appreciate the current panorama in the institutions in which palliative care medical services are being provided and consider when to offer the blood products to a patient at the end of life as a therapeutic measure in the context of a human being cared by physicians. Mención de responsabilidad : AP Brome Uribe, LM Martínez Sánchez, L Herrera-Almanza, M Fonseca-Guzmán, C Durango-Sánchez, V Vasquez-Estrada, L Duque-Echeverri, A Morales-Montoya, ME Saavedra-Valencia, JF Vargas-Silva, SM Molina-Giraldo DOI (Digital Object Identifier) : 10.20986/resed.2022.3956/2021 Derechos de uso : CC BY-NC-ND En línea : https://www.resed.es/transfusiones-al-final-de-la-vida-en-pacientes-con-diagnost [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5991

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001961	AC-2021-156	Archivo digital	Producción Científica	Artículos científicos	Disponible

Documentos electrónicos

AC-2021-156 Adobe Acrobat PDF

Subjective cognitive and communicative complaints and health-related quality of life in Parkinson's disease with and without mild cognitive impairment / Leonardo Fabio Moreno Gómez  

Público ISBD Título : Subjective cognitive and communicative complaints and health-related quality of life in Parkinson's disease with and without mild cognitive impairment Otros títulos : Quejas subjetivas cognitivas y comunicativas y calidad de vida relacionada con la salud en la enfermedad de Parkinson con y sin deterioro cognitivo leve Tipo de documento : documento electrónico Autores : Leonardo Fabio Moreno Gómez, Fecha de publicación : 2021 Títulos uniformes : Revista Colombiana de Psiquiatría Idioma : Inglés (eng) Palabras clave : Parkinson’s disease  Health-related quality of life  Quality of life  Cognitive decline  Mild cognitive impairment Resumen : Introduction: Mild Cognitive Impairment (MCI) is common in Parkinson's Disease (PD). Few studies have compared the Health-Related Quality of Life (HRQoL) in patients with and without MCI due to PD (PD-MCI), and its correlation to patients’ subjective cognitive and communicative difficulties has not been explored. Objective: We aimed to compare HRQoL in PD-MCI and PD without MCI (PD-nMCI), and explore its possible relationship to subjective cognitive and communicative complaints. Methods: We included 29 PD-nMCI and 11 PD-MCI patients. The HRQoL was assessed with the Parkinson's Disease Questionnaire-39 (PDQ-39): its Cognition dimension was used as a measure of subjective cognitive complaints, its Communication dimension for subjective communicative complaints, and the summary index (PDQ-39 SI) as an indicator of HRQoL. Non-parametric partial correlations between the Cognition and Communication dimensions, and the adjusted PDQ-39 SI were conducted. Results: PD-MCI patients had greater subjective cognitive and communicative complaints and worse HRQoL than PD-nMCI patients. In the PD-MCI group, both subjective cognitive and communicative complaints exhibited significant direct correlations with the adjusted HRQoL scores. Conclusions: HRQoL seems to be affected in PD-MCI, and it might be influenced by greater subjective cognitive and communicative complaints. Including patient-reported outcome measures of HRQoL, and providing cognitive and speech rehabilitation, as well as psychotherapeutic strategies to face these deficits can enhance the patient-centred approach in PD. Mención de responsabilidad : Alberto Jaramillo-Jimenez, Yamile Bocanegra, Omar Buriticá, David Antonio Pineda Salazar, Leonardo Moreno Gómez, Carlos Andrés Tobón Quintero, Daniel Camilo Aguirre-Acevedo, Melissa Sierra Castrillon, Daniel Vasquez, Juan Esteban Velez-Hernandez, Miguel Germán Borda, Elkin García-Cifuentes, David Fernando Aguillón, Lucía Madrigal-Zapata, Dag Aarsland y Francisco Lopera Referencia : Rev Colomb Psiquiatr (Engl Ed). 2021 Sep 3;S0034-7450(21)00134-7. DOI (Digital Object Identifier) : 10.1016/j.rcp.2021.07.005 PMID : 34489098 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0034745021001347 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5869 Subjective cognitive and communicative complaints and health-related quality of life in Parkinson's disease with and without mild cognitive impairment = Quejas subjetivas cognitivas y comunicativas y calidad de vida relacionada con la salud en la enfermedad de Parkinson con y sin deterioro cognitivo leve [documento electrónico] / Leonardo Fabio Moreno Gómez,  . - 2021. Obra : Revista Colombiana de Psiquiatría Idioma : Inglés (eng) Palabras clave : Parkinson’s disease  Health-related quality of life  Quality of life  Cognitive decline  Mild cognitive impairment Resumen : Introduction: Mild Cognitive Impairment (MCI) is common in Parkinson's Disease (PD). Few studies have compared the Health-Related Quality of Life (HRQoL) in patients with and without MCI due to PD (PD-MCI), and its correlation to patients’ subjective cognitive and communicative difficulties has not been explored. Objective: We aimed to compare HRQoL in PD-MCI and PD without MCI (PD-nMCI), and explore its possible relationship to subjective cognitive and communicative complaints. Methods: We included 29 PD-nMCI and 11 PD-MCI patients. The HRQoL was assessed with the Parkinson's Disease Questionnaire-39 (PDQ-39): its Cognition dimension was used as a measure of subjective cognitive complaints, its Communication dimension for subjective communicative complaints, and the summary index (PDQ-39 SI) as an indicator of HRQoL. Non-parametric partial correlations between the Cognition and Communication dimensions, and the adjusted PDQ-39 SI were conducted. Results: PD-MCI patients had greater subjective cognitive and communicative complaints and worse HRQoL than PD-nMCI patients. In the PD-MCI group, both subjective cognitive and communicative complaints exhibited significant direct correlations with the adjusted HRQoL scores. Conclusions: HRQoL seems to be affected in PD-MCI, and it might be influenced by greater subjective cognitive and communicative complaints. Including patient-reported outcome measures of HRQoL, and providing cognitive and speech rehabilitation, as well as psychotherapeutic strategies to face these deficits can enhance the patient-centred approach in PD. Mención de responsabilidad : Alberto Jaramillo-Jimenez, Yamile Bocanegra, Omar Buriticá, David Antonio Pineda Salazar, Leonardo Moreno Gómez, Carlos Andrés Tobón Quintero, Daniel Camilo Aguirre-Acevedo, Melissa Sierra Castrillon, Daniel Vasquez, Juan Esteban Velez-Hernandez, Miguel Germán Borda, Elkin García-Cifuentes, David Fernando Aguillón, Lucía Madrigal-Zapata, Dag Aarsland y Francisco Lopera Referencia : Rev Colomb Psiquiatr (Engl Ed). 2021 Sep 3;S0034-7450(21)00134-7. DOI (Digital Object Identifier) : 10.1016/j.rcp.2021.07.005 PMID : 34489098 En línea : https://linkinghub.elsevier.com/retrieve/pii/S0034745021001347 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5869

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD001807	AC-2021-119	Archivo digital	Producción Científica	Artículos científicos	Disponible

Psychometric validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the spanish language / Álvaro Enrique Sanabria Quiroga ; Enna Catalina Payán Gómez  

Público ISBD Título : Psychometric validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the spanish language Tipo de documento : documento electrónico Autores : Álvaro Enrique Sanabria Quiroga, ; Enna Catalina Payán Gómez, Fecha de publicación : 2016 Títulos uniformes : Journal of Pain and Symptom Management Idioma : Inglés (eng) Palabras clave : Head and neck cancer  symptoms  inventory  M. D. Anderson  quality of life Resumen : Context: The assessment of cancer-related symptoms requires culturally adapted and psychometrically validated symptom assessment tools. The M. D. Anderson Symptom InventoryeHead and Neck Module (MDASI-HN) is a useful instrument for measuring symptom burden that was specifically developed for head and neck cancer patients. Objectives: To validate the Spanish version of the MDASI-HN. Methods. We evaluated the psychometric features of the MDASI-HN in patients with head and neck cancer. We evaluated the item-scale correlations and the internal consistency. We conducted principal axis factoring to identify the underlying dimensions as a measure of construct validity. The convergence/concurrent validity was assessed with the University of Washington Quality of Life Questionnaire for Head and Neck Patients, and known-group validity and test-retest reliability also were assessed. Results. One hundred thirty patients were included. The mean SD age was 60.5 13.6 years; 68% of patients were male, 42% had laryngeal tumors, and 45.9% had Stage III tumors. Forty-seven percent of the patients underwent surgery, 55% underwent radiotherapy, and 36% underwent chemotherapy. The global Cronbach alpha for the HN module was 0.81. The factor analysis identified two factors (Factor 1: speech, mucus, coughing, and constipation; Factor 2: teeth, taste, sores, swallowing, and skin). The correlation with the global score of the University of Washington Quality of Life was 0.68. The difference in the MDASI-HN scores according to Eastern Cooperative Oncology Group performance status was statistically significant (2.72 vs. 4.01, P 1⁄4 0.006). The intraclass test-retest correlation was 0.62. Conclusion: The Spanish version of the MDASI-HN is reliable and valid for evaluating cancer-related symptoms in head and neck cancer patients. Mención de responsabilidad : Daniel Sánchez, Andrés Chala, Andrés Alvarez, Catalina Payan, Tito Mendoza, Charles Cleeland, Alvaro Sanabria Referencia : J Pain Symptom Manage. 2016 Jun;51(6):1055-61. DOI (Digital Object Identifier) : 10.1016/j.jpainsymman.2015.12.320 PMID : 26899822 En línea : https://www.jpsmjournal.com/article/S0885-3924(16)00060-9/fulltext Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3971 Psychometric validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the spanish language [documento electrónico] / Álvaro Enrique Sanabria Quiroga, ; Enna Catalina Payán Gómez,  . - 2016. Obra : Journal of Pain and Symptom Management Idioma : Inglés (eng) Palabras clave : Head and neck cancer  symptoms  inventory  M. D. Anderson  quality of life Resumen : Context: The assessment of cancer-related symptoms requires culturally adapted and psychometrically validated symptom assessment tools. The M. D. Anderson Symptom InventoryeHead and Neck Module (MDASI-HN) is a useful instrument for measuring symptom burden that was specifically developed for head and neck cancer patients. Objectives: To validate the Spanish version of the MDASI-HN. Methods. We evaluated the psychometric features of the MDASI-HN in patients with head and neck cancer. We evaluated the item-scale correlations and the internal consistency. We conducted principal axis factoring to identify the underlying dimensions as a measure of construct validity. The convergence/concurrent validity was assessed with the University of Washington Quality of Life Questionnaire for Head and Neck Patients, and known-group validity and test-retest reliability also were assessed. Results. One hundred thirty patients were included. The mean SD age was 60.5 13.6 years; 68% of patients were male, 42% had laryngeal tumors, and 45.9% had Stage III tumors. Forty-seven percent of the patients underwent surgery, 55% underwent radiotherapy, and 36% underwent chemotherapy. The global Cronbach alpha for the HN module was 0.81. The factor analysis identified two factors (Factor 1: speech, mucus, coughing, and constipation; Factor 2: teeth, taste, sores, swallowing, and skin). The correlation with the global score of the University of Washington Quality of Life was 0.68. The difference in the MDASI-HN scores according to Eastern Cooperative Oncology Group performance status was statistically significant (2.72 vs. 4.01, P 1⁄4 0.006). The intraclass test-retest correlation was 0.62. Conclusion: The Spanish version of the MDASI-HN is reliable and valid for evaluating cancer-related symptoms in head and neck cancer patients. Mención de responsabilidad : Daniel Sánchez, Andrés Chala, Andrés Alvarez, Catalina Payan, Tito Mendoza, Charles Cleeland, Alvaro Sanabria Referencia : J Pain Symptom Manage. 2016 Jun;51(6):1055-61. DOI (Digital Object Identifier) : 10.1016/j.jpainsymman.2015.12.320 PMID : 26899822 En línea : https://www.jpsmjournal.com/article/S0885-3924(16)00060-9/fulltext Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3971

Reserva

Reservar este documento

Ejemplares(1)

Código de barras	Número de Ubicación	Tipo de medio	Ubicación	Sección	Estado
DD000559	AC-2016-034	Archivo digital	Producción Científica	Artículos científicos	Disponible